From: The quest for an effective and safe personalized cell therapy using epigenetic tools
Group | Example | Current status |
---|---|---|
Short-chain fatty acid | Valproic acid | Phase II CT |
Phenyl butyrate | Phase II CT | |
Pivanex | Phase II CT | |
Hydroxamic acids | Vorinostat | FDA approved |
Panobinostat | Phase III CT | |
Belinostat | Phase II CT | |
Abexinostat | Phase II CT | |
Resminostat | Phase II CT | |
Givinostat | Phase II CT | |
Dacinostat | Phase II CT | |
Pracinostat | Phase II CT | |
Cyclic tetrapeptide | Romidepsin | FDA approved |
Apicidin | Phase II CT | |
Trapoxin A | No data | |
Benzamide | Mocetinostat | Phase II CT |
Entinostat | Phase II CT | |
Rocilinostat | Phase II CT |